The 20 Best Adult Soft Tissue Sarcoma Doctors Near Me in Alexandria, VA

Jeffrey Toretsky is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Toretsky is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Bone Marrow Aspiration.

Dr. Nicole Laslett is a specialty care physician board certified in internal medicine, medical oncology, and hematology. She joined Inova in 2025 and has been practicing since 2015. Prior to joining Inova, Dr. Laslett served as a physician at Christiana Care Oncology Hematology at the Helen F. Graham Cancer Center and Research Institute in Newark, DE, where she was also a Core Faculty member. Additionally, she held academic appointments as a Clinical Assistant Professor of Medicine at both Thomas Jefferson University and the Philadelphia College of Osteopathic Medicine. Dr. Laslett is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Breast Cancer.

Paul Meltzer is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Meltzer is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, Rhabdomyosarcoma, and Pancreaticoduodenectomy.

John Feigert is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Feigert is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Multiple Myeloma, and Chronic Lymphocytic Leukemia (CLL).

Robert Christie is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

Matthew Ladra, M.D., M.P.H., leads the dedicated pediatric team for the Johns Hopkins Proton Therapy Center and is the director of pediatric radiation oncology for the Johns Hopkins Kimmel Cancer Center, a clinical collaboration with Children’s National Hospital, where Dr. Ladra serves as faculty in the department of pediatric oncology. He is also an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine. Listen Dr. Ladra's Cancer Matters podcast episode to learn more about his work. Previously, Dr. Ladra served as the director of pediatric radiation at the Provision Center for Proton Therapy in Tennessee. He also completed a 2-year fellowship in pediatric proton therapy at the Massachusetts General Hospital’s Francis H. Burr Proton Center. Dr. Ladra is one of a handful of radiation oncologists whose research and clinical efforts focus exclusively on pediatric patients. He is frequently invited to speak on pediatric radiation oncology topics internationally and across the U.S. and has published extensively on the subject through original research book chapters and review articles. Dr. Ladra’s research efforts focus mainly on pediatric rhabdomyosarcoma treatment, early phase clinical trials involving radiation and non-chemotherapeutic agents, and reducing neurocognitive toxicity for pediatric brain tumor patients. LinkedIn https://www.linkedin.com/in/matthew-ladra-3094a316. Dr. Ladra is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Muscle Invasive Bladder Cancer, Adult Soft Tissue Sarcoma, and Ependymoma. Dr. Ladra is board certified in American Board Of Radiology.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy. Dr. Deville is board certified in American Board Of Radiology.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine.

Alina Huang is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Huang is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Pulmonary Embolism.

Ivan Aksentijevich is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Aksentijevich is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma.

Jacob Ninan is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Ninan is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Pulmonary Embolism, Saddle Pulmonary Embolism, and Colorectal Cancer.

Keith Unger is a Radiation Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Unger is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Anal Cancer, Adult Soft Tissue Sarcoma, and Pancreaticoduodenectomy.

Dennis Priebat is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Priebat is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Rhabdomyosarcoma Embryonal.

Robert Henshaw is an Orthopedics provider practicing medicine in Washington, Washington, D.c.. Dr. Henshaw is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, Osteotomy, and Bone Graft.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer. Dr. Kumar is board certified in American Board Of Radiology.

Dr. Michail Mavros, a surgical oncologist specializing in complex cancers, is deeply committed to offering his patients personalized, advanced care. Originally from Athens, Greece, Dr. Mavros's passion for oncology was sparked during medical school after losing a close friend to cancer. This life-changing event inspired him to dedicate his career to improving the lives of cancer patients. Dr. Mavros is one of few surgeons with accredited subspecialty training in both complex surgical oncology and hepato-pancreato-biliary (HPB) surgery, making him highly qualified to treat cancers of the liver, pancreas, and bile ducts. He is also skilled in minimally invasive techniques, including laparoscopic and robotic-assisted surgery, which offer benefits such as faster recovery, reduced pain, and improved outcomes. At the heart of Dr. Mavros' approach is his belief in individualized care. He works closely with a multidisciplinary team of experts, including medical oncologists, radiation oncologists, and pathologists, to ensure each patient receives a thorough evaluation. This collaborative approach results in comprehensive, personalized treatment plans. By leveraging the latest advances in precision medicine, Dr. Mavros tailors his treatments to meet the unique needs of each patient, guided by the most current scientific research and evidence-based practices. Dr. Mavros is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Mavros is board certified in American Board Of Surgery.

Dr. Mildred R. Chernofsky is a gynecologic oncologist at Sibley Memorial Hospital and an associate professor in obstetrics and gynecology at George Washington University School of Medicine and the Uniformed Services University of the Health Sciences (USUHS). She practices out of the Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery. Dr. Chernofsky is affiliated with Sibley Memorial Hospital and George Washington University Hospital. With a focus on gynecology and obstetrics, Dr. Chernofsky has an expertise in advanced laparoscopy, gestational trophoblastic disease and robotic surgery. Dr. Chernofsky earned her medical degree from Pennsylvania State University College of Medicine. She completed a general internship and a residency in obstetrics and gynecology at the National Naval Medical Center of San Diego, as well as a fellowship in gynecologic oncology at the Los Angeles County/University of Southern California Medical Center. Dr. Chernofsky was named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly in 2012 and 2014. She was also named a Top Doctor in the D.C. region by Washingtonian Magazine. Dr. Chernofsky is also a fellow of the American Congress of Obstetricians and Gynecologists. Dr. Chernofsky has clinical interests in uterine, ovarian, cervical and vulvar cancers, as well as genital dysplasia. She has contributed to numerous clinical trials in her position as a principal investigator for Gynecologic Oncology Group (GOG), as well as various publications and presentations. Dr. Chernofsky also participates in patient educational forums both locally and those sponsored by the Foundation for Women’s Cancer. Dr. Chernofsky is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Hysterectomy. Dr. Chernofsky is board certified in American Board Of Obstetrics And Gynecology.